References
- Mayer G. Antibiotics – protein synthesis, nucleic acid synthesis, and metabolism. In: Microbiol. Immunol. Hunt RC ( Ed.). University of South Carolina, SC, USA (2016). http://www.microbiologybook.org/mayer/antibiot.htm.
- Sievert DM, Ricks P, Edwards JR et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010. Infect. Control Hosp. Epidemiol. 34(1), 1–14 (2013).
- Bulik CC, Fauntleroy KA, Jenkins SG et al. Comparison of meropenem MICs and susceptibilities for carbapenemase- producing Klebsiella pneumoniae isolates by various testing methods. J. Clin. Microbiol. 48(7), 2402–2406 (2010).
- Clinical and Laboratory Standards Institute. In: Performance Standards for Antimicrobial Susceptibility Testing; 22nd Informational Supplement (Vol 32). Clinical and Laboratory Standards Institute, PA, USA (2012).
- Clinical and Laboratory Standards Institute. In: Performance Standards for Antimicrobial Susceptibility Testing. 27th M100. Clinical and Laboratory Standards Institute, PA, USA (2017).
- Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenem-resistant Enterobacteriaceae: Epidemiology and prevention. Clin. Infect. Dis. 53(1), 60–67 (2011).
- Hindiyeh M, Smollen G, Grossman Z et al. Rapid detection of blaKPC carbapenemase genes by real-time PCR. J. Clin. Microbiol. 46(9), 2879–2883 (2008).
- Tenover FC, Kalsi RK, Williams PP et al. Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing. Emerg. Infect. Dis. 12(8), 1209–1213 (2006).
- Deshpande LM, Jones RN, Fritsche TR, Sader HS. Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program (2000–2004). Microb. Drug Resist. 12(4), 223–230 (2006).
- Stuart A. A test for homogeneity of the marginal distributions in a two-way classification. Biometrika 42(3/4), 412–416 (1955).
- Maxwell A. Comparing the classification of subjects by two independent judges. Br. J. Psychiatry 116(535), 651–655 (1970).
- Jovanovic BD, Levy PS. A look at the rule of three. Am. Stat. 51(2), 137–139 (1997).
- Browne R. Letters to the editor. Am. Stat. 51(3), 252 (2002).
- Clinical and Laboratory Standards Institute. In: Performance Standards for Antimicrobial Susceptibility Testing, 19th Information Supplement (M100-S19). Clinical and Laboratory Standards Institute, PA, USA (2009).
- Hombach M, Bloemberg GV, BöTtger EC. Effects of clinical breakpoint changes in CLSI guidelines 2010/2011 and EUCAST guidelines 2011 on antibiotic susceptibility test reporting of Gram-negative bacilli. J. Antimicrob. Chemother. 67(3), 622–632 (2012).
- Magiorakos AP, Srinivasan A, Carey RB et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 18(3), 268–281 (2012).
- Mathers AJ, Peirano G, Pitout DD. The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae. Clin. Microbiol. Rev. 28(3), 565–591 (2015).
- Endimiani A, Perez F, Bajaksouzian S et al. Evaluation of updated interpretative criteria for categorizing Klebsiella pneumoniae with reduced carbapenem susceptibility. J. Clin. Microbiol. 48(12), 4417–4425 (2010).
- Centers for Disease Control and Prevention (CDC). CRE toolkit-guidance for control of carbapenem-resistant Enterobacteriaceae (CRE) (2015). www.cdc.gov/hai/organisms/cre/cre-toolkit/.